Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
Amylyx Pharmaceuticals (Nasdaq: AMLX) has scheduled its third quarter 2024 financial results announcement for Thursday, November 7, 2024. The company will host a conference call and audio webcast at 8:00 a.m. ET, where senior management will discuss financial results and company updates. Participants can join via phone or watch the webcast through the company's investor relations website, where it will remain available for replay for 90 days.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha programmato l'annuncio dei suoi risultati finanziari del terzo trimestre 2024 per giovedì 7 novembre 2024. L'azienda ospiterà una conference call e un webcast audio alle 8:00 ET, durante il quale la direzione discuterà i risultati finanziari e gli aggiornamenti aziendali. I partecipanti possono unirsi tramite telefono o guardare il webcast attraverso il sito web delle relazioni con gli investitori dell'azienda, dove rimarrà disponibile per la replica per 90 giorni.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el jueves 7 de noviembre de 2024. La empresa organizará una llamada de conferencia y un webcast de audio a las 8:00 a.m. ET, donde la alta dirección discutirá los resultados financieros y las actualizaciones sobre la empresa. Los participantes pueden unirse por teléfono o ver el webcast a través del sitio web de relaciones con inversores de la empresa, donde estará disponible para reproducción durante 90 días.
아미릭스 제약 (Nasdaq: AMLX)는 2024년 3분기 재무 결과 발표를 2024년 11월 7일 목요일로 예정했습니다. 회사는 동부 표준시 기준 오전 8시에 경영진이 재무 결과 및 기업 업데이트에 대해 논의하는 전화 회의 및 오디오 웹캐스트를 진행합니다. 참가자는 전화를 통해 참여할 수 있으며, 회사의 투자자 관계 웹사이트를 통해 웹캐스트를 시청할 수 있으며, 해당 웹캐스트는 90일 동안 다시 시청할 수 있습니다.
Amylyx Pharmaceuticals (Nasdaq: AMLX) a programmé l'annonce de ses résultats financiers du troisième trimestre 2024 pour le jeudi 7 novembre 2024. L'entreprise organisera une conférence téléphonique et un webinaire audio à 8h00 HE, au cours de laquelle la direction discutera des résultats financiers et des mises à jour de l'entreprise. Les participants peuvent se joindre par téléphone ou regarder le webinaire via le site web des relations investisseurs de la société, qui restera disponible en replay pendant 90 jours.
Amylyx Pharmaceuticals (Nasdaq: AMLX) hat die Bekanntgabe der Finanzergebnisse für das dritte Quartal 2024 für Donnerstag, den 7. November 2024, geplant. Das Unternehmen wird um 8:00 Uhr ET eine Telefonkonferenz und einen Audio-Webcast veranstalten, in dem die Geschäftsführung die Finanzergebnisse und Unternehmensaktualisierungen besprechen wird. Teilnehmer können telefonisch teilnehmen oder den Webcast über die Investor-Relations-Website des Unternehmens ansehen, der für 90 Tage im Replay verfügbar bleibt.
- None.
- None.
To access the conference call, please dial +1 (800)-836-8184 (
About Amylyx Pharmaceuticals
Amylyx is committed to the discovery and development of new treatment options for communities with high unmet needs, including people living with serious and fatal neurodegenerative diseases and endocrine conditions. Since its founding, Amylyx has been guided by science to address unanswered questions, keeping communities at the heart and center of all decisions. Amylyx is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241104724721/en/
Media
Amylyx Media Team
+1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors
Lindsey Allen
Amylyx Pharmaceuticals, Inc.
+1 (857) 320-6244
Investors@amylyx.com
Source: Amylyx Pharmaceuticals, Inc.
FAQ
When will Amylyx Pharmaceuticals (AMLX) report Q3 2024 earnings?
How can I listen to Amylyx Pharmaceuticals (AMLX) Q3 2024 earnings call?
What time is Amylyx Pharmaceuticals (AMLX) Q3 2024 earnings call?
